Literature DB >> 2273613

A successfully treated case of Vibrio vulnificus septicemia with shock.

K Kikawa1, K Yamasaki, T Sujiura, H Myose, M Chinen, K Tsutsumi, N Iwao, T Dohzono.   

Abstract

Vibrio vulnificus infection often causes serious or fatal disease. Recently, in Japan there have been numerous reports of Vibrio vulnificus infection. Here, we report a successfully treated case of Vibrio vulnificus septicemia with shock, disseminated intravascular coagulation (DIC) and necrotizing cellulitis in a middle-aged heavy drinker with chronic alcoholic liver disease. On reviewing 38 cases in Japan including ours, the overall mortality rate was 68%. Although the incidence is relatively low, it is recommended to warn patients in the high risk category, such as liver disease patients, to avoid raw fish and shellfish and limit sea water exposure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273613     DOI: 10.2169/internalmedicine1962.29.313

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  4 in total

1.  Vibrio furnissii: an unusual cause of bacteremia and skin lesions after ingestion of seafood.

Authors:  Catherine Derber; Philip Coudron; Cheryl Tarr; Lori Gladney; Maryann Turnsek; Shivanjali Shankaran; Edward Wong
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

2.  Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.

Authors:  S J Devi; U Hayat; J L Powell; J G Morris
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates.

Authors:  Gary P Richards; Alberto Nuñez
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

Review 4.  Distribution of Fatal Vibrio Vulnificus Necrotizing Skin and Soft-Tissue Infections: A Systematic Review and Meta-Analysis.

Authors:  Kuo-Chin Huang; Hsu-Huei Weng; Tien-Yu Yang; Te-Sheng Chang; Tsan-Wen Huang; Mel S Lee
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.